dactinomycin has been researched along with n-benzyloxycarbonyl-leucyl-leucyl-phenylalaninal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Orlowski, RZ; Shi, YY; Small, GW | 1 |
1 other study(ies) available for dactinomycin and n-benzyloxycarbonyl-leucyl-leucyl-phenylalaninal
Article | Year |
---|---|
Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis.
Topics: Apoptosis; Breast Neoplasms; Butadienes; Chymotrypsin; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dactinomycin; Enzyme Inhibitors; Female; Flavonoids; Humans; Kinetics; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Nitriles; Oligopeptides; Proteasome Endopeptidase Complex; Tumor Cells, Cultured | 2002 |